Navidea生物制药(NAVB)

1.878 0.088 4.9162%

今开:1.49昨收:1.79
最高:1.88 最低:1.49
涨停价:0.0跌停价:0.0
总市值:5.4509724E7

Navidea生物制药的热门评论

Navidea生物制药(NAVB)2020-09-17 18:06

$Navidea生物制药(NAVB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-002467 Act: 33 Size: 1 KB 网页链接查看全文

Navidea生物制药(NAVB)2019-08-13 14:55

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-08-12 AccNo: 0001437749-19-016374 Size: 43 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接查看全文

Navidea生物制药(NAVB)2020-09-03 19:42

$Navidea生物制药(NAVB)$ 内部交易: 2020-08-30,10% Owner,Scott John K Jr. ,买入,5000普通股, $5.00查看全文

Navidea生物制药(NAVB)2020-09-03 05:36

$Navidea生物制药(NAVB)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-20-019241 Act: 33 Size: 564 KB 网页链接查看全文

Navidea生物制药(NAVB)2020-09-03 05:21

$Navidea生物制药(NAVB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-20-238219 Act: 34 Size: 49 KB 网页链接查看全文

Navidea生物制药(NAVB)2020-09-03 05:36

$Navidea生物制药(NAVB)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-20-019242 Act: 33 Size: 527 KB 网页链接查看全文

Navidea生物制药(NAVB)2020-09-02 18:06

$Navidea生物制药(NAVB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-002328 Act: 33 Size: 1 KB 网页链接查看全文

Navidea生物制药(NAVB)2020-09-03 09:51

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001753763-20-000002 Size: 8 KB 网页链接查看全文

Navidea生物制药(NAVB)2020-08-28 20:27

$Navidea生物制药(NAVB)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001437749-20-018885 Act: 33 Size: 50 KB 网页链接查看全文

Navidea生物制药(NAVB)2020-08-26 04:12

$Navidea生物制药(NAVB)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001437749-20-018666 Act: 33 Size: 413 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Navidea生物制药的最新评论

Navidea生物制药(NAVB)06-15 23:51

$Navidea生物制药(NAVB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-21-081310 Act: 34 Size: 54 KB 网页链接查看全文

Navidea生物制药(NAVB)05-25 18:06

$Navidea生物制药(NAVB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-002085 Act: 33 Size: 1 KB 网页链接查看全文

Navidea生物制药(NAVB)05-14 04:45

$Navidea生物制药(NAVB)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001437749-21-012089 Act: 33 Size: 391 KB 网页链接查看全文

Navidea生物制药(NAVB)05-14 04:12

$Navidea生物制药(NAVB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-012043 Act: 34 Size: 5 MB 网页链接查看全文

Navidea生物制药(NAVB)05-12 04:42

$Navidea生物制药(NAVB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-21-011697 Act: 34 Size: 100 KB 网页链接查看全文

Navidea生物制药(NAVB)05-12 04:18

$Navidea生物制药(NAVB)$ 8-K Current report, item 5.02 Accession Number: 0001437749-21-011698 Act: 34 Size: 20 KB 网页链接查看全文

Navidea生物制药(NAVB)05-07 06:45

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-011198 Size: 6 KB 网页链接查看全文

Navidea生物制药(NAVB)05-07 06:42

$Navidea生物制药(NAVB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-011196 Size: 2 KB 网页链接查看全文

Navidea生物制药(NAVB)05-06 05:27

$Navidea生物制药(NAVB)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001437749-21-010937 Act: 34 Size: 37 KB 网页链接查看全文

Navidea生物制药(NAVB)04-27 07:33

$Navidea生物制药(NAVB)$ 内部交易: 2021-04-23,Director,Witter Malcolm G ,买入,10000普通股, $1.60查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Navidea生物制药的公告

$Navidea生物制药(NAVB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-21-081310 Act: 34 Size: 54 KB 网页链接

$Navidea生物制药(NAVB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-002085 Act: 33 Size: 1 KB 网页链接

$Navidea生物制药(NAVB)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001437749-21-012089 Act: 33 Size: 391 KB 网页链接

$Navidea生物制药(NAVB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-012043 Act: 34 Size: 5 MB 网页链接

$Navidea生物制药(NAVB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-21-011697 Act: 34 Size: 100 KB 网页链接

$Navidea生物制药(NAVB)$ 8-K Current report, item 5.02 Accession Number: 0001437749-21-011698 Act: 34 Size: 20 KB 网页链接

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-011198 Size: 6 KB 网页链接

$Navidea生物制药(NAVB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-011196 Size: 2 KB 网页链接

$Navidea生物制药(NAVB)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001437749-21-010937 Act: 34 Size: 37 KB 网页链接

$Navidea生物制药(NAVB)$ 内部交易: 2021-04-23,Director,Witter Malcolm G ,买入,10000普通股, $1.60

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32